Spots Global Cancer Trial Database for Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Official Title: Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Study ID: NCT00803530
Conditions
Interventions
Study Description
Brief Summary: This is a prospective, multicenter phase II trial designed to evaluate the safety and activity of the combination of association of arsenic trioxide (ATO) and ascorbic acid in patients with myelodysplastic syndromes
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ospedale SS Antonio, Biagio e Cesare Arrigo, Alessandria, , Italy
Ospedale Cardinal Massaia, Asti, , Italy
Spedali Civili, Brescia, , Italy
Ospedale Maggiore, Chieri, , Italy
Ospedale civico di Chivasso, Chivasso (TO), , Italy
Ospedale Santa Croce e Carle, Cuneo, , Italy
AOS San Gerardo de' Tintori, Monza, , Italy
Università Avogadro Divisione di Ematologia, Novara, , Italy
Ospedale San Luigi Gonzaga Divisione di Ematologia, Orbassano (TO), , Italy
Azienda Ospedaliera Perugia, Perugia, , Italy
Ospedale San Giovanbni Battista-Molinette, Torino, , Italy
Ospedale San Giovanni Battista -Molinette, Torino, , Italy
Ospedale San Bortolo, Vicenza, , Italy
Contact Details
Name: Alessandro Levis, MD
Affiliation: S.O.C. di Ematologia, Azienda Ospedaliera SS Antonio e Biagio, Alessandria. Via Venezia 18 - 15100 - Alessandria
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
